GDF11 maintains erythroid precursors in a sustained dedifferentiation state and is a potential target to treat ineffective hematopoiesis in diseases such as myelodysplastic syndromes and β-thalassemia37, 38. This evidence concerns the gene GDF11 and myelodysplastic syndrome.